FIELD: medicine, oncology. SUBSTANCE: the present innovation deals with chemotherapy due to injecting a cytostatic, the total therapeutic dose of which is first introduced fractionally into patient's ischium with equal dosages once per three days. The quantity of courses is determined as dependent upon individual tolerance and the result obtained. At treating patients at the age of above 80 and those with contraindications to conduct systemic chemotherapy it is necessary to decrease the dose two-fold. EFFECT: higher efficiency of therapy. 1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING LOCALLY METASTASING FORMS BLADDER'S CANCER | 2004 |
|
RU2260434C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH DISSEMINATED PROSTATE CANCER FORMS | 2004 |
|
RU2260430C1 |
| METHOD OF COMBINED TREATMENT OF MUSCULO-INVASIVE BLADDER CANCER T3-T4 N0-+M0 | 2019 |
|
RU2713443C2 |
| METHOD FOR COMBINED TREATMENT OF STOMACH CANCER WITH LIMITED PERITONEAL DISSEMINATION | 2021 |
|
RU2763665C2 |
| METHOD OF NEOADJUVANT CHEMOTHERAPY OF INVASIVE BLADDER CANCER | 2008 |
|
RU2368381C1 |
| METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
| METHOD OF THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER OF IB3-IIIB STAGES | 2022 |
|
RU2799247C2 |
| COMBINED METHOD FOR TREATING DISSEMINATED STOMACH CANCER CASES | 2003 |
|
RU2270677C2 |
| METHOD FOR COMBINED NEOADJUVANT POLYCHEMOTHERAPY OF CERVICAL CANCER PATIENTS | 2015 |
|
RU2595855C1 |
| METHOD OF TREATING PROSTATE CANCER WITH USING PROLONGED PRODRUG OF OCTREOTIDE ACCOMPANYING SURGICAL OR DRUG-INDUCED CASTRATION | 2013 |
|
RU2541810C2 |
